The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs

Abstract

Our findings suggest significantly greater, but perhaps less selective use of coxibs among specialists, even after accounting for important covariates. The initiation and discontinuation of coxibs was influenced by physician specialty and by patient risk factors.